SARA BEELER: Open Payments
NPI 1720328198 · TAMPA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$61,186 in 292 payments from 48 companies in 2025. Trend: 2023 $63,629 · 2024 $98,907 · 2025 $61,186
Speaker / faculty: $47,800Food & beverage: $6,966Travel & lodging: $3,745Consulting: $2,675
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 69 | $45,936 |
| Daiichi Sankyo Inc. | 24 | $10,824 |
| Novartis Pharmaceuticals Corporation | 22 | $460 |
| ABBVIE INC. | 10 | $300 |
| Incyte Corporation | 12 | $270 |
| PFIZER INC. | 11 | $266 |
| E.R. Squibb & Sons, L.L.C. | 15 | $265 |
| Janssen Biotech, Inc. | 11 | $255 |
| Gilead Sciences, Inc. | 10 | $221 |
| TerSera Therapeutics LLC | 8 | $220 |
Products named: Enhertu, IMFINZI, DATROWAY, LYNPARZA, Trodelvy, Zoladex, OPDIVO, IMBRUVICA.
Industry payments across FL — which companies pay providers there.
